![]() | Up a level |
Augustin, M., Hallek, M. and Nitschmann, S. (2022). Antibody Therapy in Patients with COVID-19. Internist, 63 (5). S. 573 - 577. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Augustin, M., Hallek, M. and Nitschmann, S. (2021). Antibody therapy in patients with COVID-19. Internist, 62 (5). S. 572 - 577. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Augustin, M., Hallek, M. and Nitschmann, S. . Development of Vaccines for Prevention of COVID-19. Internist. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Augustin, M., Hallek, M. and Nitschmann, S. (2021). Development of Vaccines for the Prevention of COVID-19-Part 2. Internist, 62 (3). S. 337 - 341. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Augustin, M., Hallek, M. and Nitschmann, S. . Development of vaccines for prevention of COVID-19: part 2. Internist. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Augustin, M., Hallek, M. and Nitschmann, S. (2021). Development of vaccines for prevention of COVID-19: part 3. Internist, 62 (6). S. 690 - 694. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Augustin, M., Hallek, M. and Nitschmann, S. (2020). Morphological and molecular Changes in the Lungs of COVID-19 Patients. Internist, 61 (12). S. 1304 - 1308. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Augustin, M., Hallek, M. and Nitschmann, S. (2020). Remdesivir for Patients with COVID-19. Internist, 61 (8). S. 869 - 873. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Augustin, M., Hallek, M. and Nitschmann, S. (2020). Remdesivir for patients with severe COVID-19. Internist, 61 (6). S. 644 - 646. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Augustin, M., Hallek, M. and Nitschmann, S. (2022). Risk of myocarditis associated with mRNA vaccines for prevention of COVID-19. Internist, 63 (4). S. 461 - 465. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Augustin, M., Hallek, M. and Nitschmann, S. (2021). Vaccine Development for Prevention of COVID-19 in Adolescents. Internist, 62 (12). S. 1360 - 1364. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Augustin, Max, Hallek, M. and Nitschmann, S. (2022). Myocarditis and pericarditis after COVID-19 mRNA vaccination. Innere Med., 63 (12). S. 1323 - 1327. Berlin: SPRINGER MEDIZIN. ISSN 2731-7099
Eichhorst, B. and Nitschmann, S. (2020). New Treatment in Patients with chronic lymphocytic Leukemia. Internist, 61 (7). S. 770 - 773. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Frerker, C., Baldus, S. and Nitschmann, S. (2019). Interventional Aortic Valve Replacement PARTNER-3 Study and Evolut Low Risk Trial. Internist, 60 (11). S. 1221 - 1225. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Halbach, M., Baldus, S. and Nitschmann, S. (2022). Shortening and De-escalation of dual Antiplatelet Therapy (2022). Internist, 63 (3). S. 346 - 347. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Krone, W. and Nitschmann, S. (2014). Mediterranean Diet for the Primary prevention of cardiovascular Disease Prevention-Diet-Mediterranean (PREDIMED)-Study. Internist, 55 (5). S. 607 - 609. NEW YORK: SPRINGER. ISSN 1432-1289
Mallmann, P. and Nitschmann, S. (2020). Menopausal hormone therapy and breast cancer risk. Internist, 61 (6). S. 647 - 651. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Vehreschild, M. J. G. T., Tsakmaklis, A. and Nitschmann, S. (2020). Intestinal Microbiota-Predictor of Mortality After Stem Cell Transplantation. Internist, 61 (9). S. 992 - 995. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289